Clinically, the staining in BRAF V600E-mutant positive cases can be weak, moderate, to strong, and the distribution can be uniform, nearly uniform, or heterogeneous in colorectal carcinoma [15]. This evidence concerns the gene BRAF and colorectal carcinoma.